Internal Medicine/Neurology

 

Jeffrey Rosenfeld, MD, PhD

Professor of Clinical Neurology
Professor, Clinical Neurology, UCSF
Director, Neuromuscular Program

 

 

 

 

 

 

 


 

  Medical School: University of Maryland
  Residency: Hospital of the University of Pennsylvania
  Graduate School: : University of Connecticut
Neuromorphology/Neuroanatomy
  Doctorate: University of Connecticut
Neuromorphology/Neuroanatomy
  Post-Doctoral Research Fellowship: Neuropathology / Neurology, Johns Hopkins School of Medicine
  Board Certified: Neurology
  Awards and Recognition:
  • American Neurologic Association ( ANA, elected membership)
  • American Academy of Neurology – Fellow (FAAN)
  • American Homecare and Hospice Physician of the Year 2006
  • Chairman, ALS Association Clinical Grant Committee.
  • MDA Annual Spirit Award 2007
  • America’s Best Doctors  2004-2008
  • Muscular Dystrophy Association Outstanding Clinic Award
  • Zeritsky Research Award, Department of Neurology, University of Pennsylvania
  • Maryland State Senatorial Scholarship
  • Combined Accelerated Program in Psychiatry (CAPP)
  • University of Maryland School of Medicine Competition, 1st, 2nd, 4th prize.
  • University of Maryland School of Medicine
  • Honors in Neurology
  • Honors in Pathology Research
  • Honors in Neuroscience
  • International Motor Neuron Disease Association – program committee

 

  Publications: (since 2009)  
   

Jackson, CE, Rosenfeld, J., Gronseth, G., Barohn, RJ, Dubinsky, R., Simpson, CB, McVey, A., King, RM, Hurbelin, L., and the Muscle Study Group. A Randomized, Double-Blind Study of Botulinum Toxon type B for Sialorrhea in Patients with ALS. Muscle Nerve 39 (2) 137-143 2009.


Strong, M. J., Grace, G. M., Freedman, M., Lomen-Hoerth, C., Woolley, S., Goldstein, L. H.,Murphy, J., Shoesmith, C., Rosenfeld, J., Nigel Leigh, P., Bruijn, L., Ince, P., Figlewicz,,D. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis FIRST publication Jan 2009


Miller RG, Jackson CD, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73 (15) 1218-26, 2009.


Miller RG, Jackson CD, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC. practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplianry care, symptom management, and cognitive-behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73 (15) 1227-33, 2009.


Chan, YM, Keramaris-Vrantsis, E., Lidov, HG, Norton, JH, Zinchenko, N., Gruber, HE, Thresher, R., Blake, DJ, Ashar, J., Rosenfeld, J., and Lu, QL.  Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.  Human Molecular Genetics  1-12 2010.


Ellis, A. and Rosenfeld, J.  Respiratory function and ventilatory assistance do not impact resting energy expenditure in amyotrophic lateral sclerosis.  The Journal of the American Dietetic Association.


Ellis AC, Rosenfeld J. Which equation best predicts energy expenditure in amyotrophic lateral sclerosis? J Am Diet Assoc. 2011 Nov; 111(11):1680-7. PMID: 22027050

Rosenfeld J. What are we measuring? Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr; 14(3):161. PMID: 23536978



Book Chapter


Rosenfeld, J.  The Motor Neuron Diseases.  In Amyotrophic Lateral Sclerosis and the Frontotemporal Dementias. Strong, MJ ed.  Oxford Press In press 2011